title: Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?".
authors.forename: John J
authors.initials: JJ
authors.lastname: Mahoney
authors.forename: Patricia
authors.initials: P
authors.lastname: Maguire
authors.forename: John M
authors.initials: JM
authors.lastname: Ellison
authors.forename: Alan T
authors.initials: AT
authors.lastname: Cariski
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D016638:Critical Illness; D005189:False Positive Reactions; D006400:Hematocrit; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000175:diagnosis*; D007362:Intensive Care Units; D008991:Monitoring, Physiologic / Q000379:methods
chemical_list: D001786:Blood Glucose